Využití natriuretických peptidů v diagnostice hypertrofie levé komory u obézních hypertoniků s metabolickým syndromem - editorial
- Pracoviště preventivní kardiologie IKEM Praha, vedoucí pracoviště doc. MUDr. Věra Adámková, CSc.
Received: November 29, 2012; Published: September 1, 2013 Show citation
References
- Sahin M, Portakal O, Karagöz T et al. Diagnostic performance of BNP and NT-Pro BNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clin Biochem 2010; 43: 1278-1281.
Go to original source...
Go to PubMed...
- Tang WH, Francis GS, Morrow DA. National Academy of Clinical biochemistry Laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 2007; 116: e99-e109.
Go to original source...
- Pan Y, Zhu W, Ma J et al. Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats. Arch Cardiovasc Dis 2011; 104: 17-28.
Go to original source...
Go to PubMed...
- Cosson S. Usefulness of B type Natriuretic Pepride (BNP) as a screen for left ventricular abnormalities in diabetes mellitus. Diabetes Metab 2004; 30: 381-386.
Go to original source...
Go to PubMed...
- Vickery S, Price CP, John I et al. Type Natriuretic Peptide (BNP) and Amino Terminal pro BNP in Patients with CKD: relationship to Renal Function and Left Ventricular Hypertrophy. Am J Kidney Dis 2005; 46: 610-620.
Go to original source...
Go to PubMed...